The key question: Will oral formulations be the real differentiator, or will scale and pricing power decide the winners in Indias #GLP-1 race
I had asked a rep if there would be a 4th of July sale and I was told no

72-week results) 2 JAMA Network (2023)Tirzepatide (SURMOUNT) obesity trials: efficacy and safety data (~20% weight loss at 15 mg weekly) 3 The Lancet (2023)Tirzepatide in type 2 diabetes: Phase 2 trial (weight loss and glycemic outcomes at 36 weeks) 4 PubMed / NEJM (2023)Tirzepatide dosing and tolerability: starting at 2 mg vs 4 mg reduces GI adverse events 5 Metabolites (PMC, 2025)TirzepatideA Game Changer in Obesity Pharmacotherapy (comprehensive review of mechanism and trials) 6 New England Journal of Medicine (2022)Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1, NEJM 2022) 7 PubMed (2025)Meta-analysis: Tirzepatide achieves ~14% greater weight reduction vs placebo with no increase in adverse events 8 Molecular Metabolism (2025)Preclinical tri-agonist NN1706 (related compound): mechanism and pharmacokinetics 9 Nature Reviews Endocrinology (2024)Dual GIP/GLP-1 receptor agonists for obesity and diabetes: a clinical landscape review 10 Journal of Cachexia, Sarcopenia and Muscle (PMC)Protein requirements during weight loss: preserving lean mass 11 GenScriptPeptide Storage and Handling Guidelines (technical bulletin for lyophilized and reconstituted peptides) 12 BachemHandling and Storage Guidelines for Peptides (technical article on stability and freeze-thaw cycles) 13 Centers for Disease Control and Prevention (CDC)Vaccine Administration: Subcutaneous Injection (technique, angle, and site guidance) 14 NCBI BookshelfInjection Administration Best Practices (aseptic technique, sharps disposal, and safety) 15 Pharmacologic Considerations of the Subcutaneous Route (PMC)Subcutaneous injection technique and site rotation to prevent lipohypertrophy 16 Prime Lab PeptidesTirzepatide (5 mg) product page (quality documentation and specifications) Tirzepatide frequently asked questions How do I reconstitute a 5 mg vial of Tirzepatide

Product specifications Based on available information from the Precision Peptide Co website and product listings, their semaglutide products include the following reported specifications: Purity claim: Third-party tested, with COA (Certificate of Analysis) reportedly available on product pages Form: Lyophilized powder requiring reconstitution before use Research use only: Not approved or intended for human consumption Quantity-based discounts: Available for bulk research orders The lyophilized powder format is standard across research peptide vendors
For instance, in Texas, which is among the top 10 state obesity rates in the country, nearly 5,000 Hims & Hers customers have shared they cannot access the care they need